Procedures that go through the cheek with a needle (percutaneous) are ablative- they work by damaging some of the fibers of the nerve that are ‘short-circuiting’. Ablative procedures are surgical, but are considered ‘minimally invasive’ treatments. Minimally invasive interventional pain therapies are possible options when drug therapy fails. In addition, for some people, MVD surgery is not suitable because of medical comorbidities or risk factors, and ablative procedures may be good alternatives. One advantage of rhizotomies is that the onset of pain relief can start within a day of the procedure. For people whose facial pain prevents them from eating, talking, or maintaining basic functions of everyday life, this quick action can make rhizotomy a good choice.
Balloon compression for trigeminal neuralgia is a simple and effective outpatient treatment for trigeminal neuralgia. It is one of the ablative options that injures the trigeminal nerve in a very specific way.
If you are not a good candidate for invasive surgical treatment and medication is not keeping your pain at a manageable level or is causing unacceptable side effects, a rhizotomy may be a good choice. If your pain consists predominantly of paresthesias, it is a consideration. Paresthesias are paroxysmal sensations that can be described as: jumping, flashing, shooting, pricking, boring, drilling, stabbing, sharp, cutting or lacerating. Balloon compression is especially indicated for those patients with stabbing pain in the region of the eyes. This is because the small fibers that do not have insulation mediate what is called the corneal reflex and thus their function is preserved. This is the reflex that protects your eye from scratches that can affect one’s vision over time.
A balloon is temporarily inserted through a needle placed through the cheek and is inflated under X-ray guidance. The balloon squeezes the trigeminal nerve root against the skull base for a selected time period at a measured pressure. The balloon only injures the insulation that individually surrounds thousands of ‘wires’ within the ‘cable’ that makes up the trigeminal nerve. By injuring this insulation, the ability of the nerve to conduct electricity is affected. It turns off the switch that allows the short-circuit upstream in the nerve to occur. It is this short circuit that leads to the electrical sensations a patient feels. Interestingly, these injured nerve fibers do not conduct pain sensation. They conduct the sensations of light touch that trigger the painful short circuit. Fibers in the nerve that conduct pain sensation are actually preserved.
Studies have shown that more than 90 percent of procedures will eliminate the pain of trigeminal neuralgia in properly selected candidates. The median duration of pain relief is about two years, and everyone is different; this means your pain could stay away for a few months, or up to eight years following a balloon compression rhizotomy. For many patients, the pain is eliminated immediately following the procedure; for others, the effects take a few days.
By injuring the trigeminal nerve, an element of numbness is introduced. 92% of patients say that this numbness is mild. Numbness is not an absence of sensation. It is another form of sensation called dysesthesia. If severe enough it can be interpreted as burning, scalding, searing, tingling, itching, stinging, cool, cold, even freezing. Such sensations result from significant nerve injury, which must be avoided. Fortunately, these are rare occurrences.
One other side effect is temporary weakness of the chewing muscles on the same side as the surgery. The trigeminal nerve has a branch that has motor function to these muscles. This can lead to temporary aching pain in the jaw joint. Such a pain is treatable with Tylenol and this weakness resolves over the course of several weeks.
The procedure takes one hour to complete. The patient is sedated during the procedure and is able to return home within a few hours with a band aid covering the needle entry site.
Pain can recur when the nerve insulation heals. Such recurrence is expected, because the planned injury is a mild one. Recurrence rate is 30% to 50% within three to five years. When pain recurs, compression can be repeated.
Percutaneous stereotactic radiofrequency rhizotomy (PSR) produces a controlled injury to the trigeminal nerve and is therefore able to trade numbness for relief of TN pain. It does so by temperature-monitored heating of the trigeminal nerve fibers. The extent of numbness can vary, but in general, the amount of numbness is proportional to the duration of relief. Too much numbness can also be a problem because it can cause uncomfortable sensations.
PSR can limit numbness to a specific part of the face, especially if the pain originates in the lower face, jaw, or tongue. It is probably the only procedure that can reliably limit numbness to that part of the face. This is helpful because the more widespread the numbness, the harder it can be to tolerate. Numbness of the upper face that includes the surface of the eye creates the risk of eye irritation or even corneal scarring with loss of vision. Absolute control of the lesion is not possible, however, and sometimes one gets more numbness than planned despite the surgeon’s best efforts.
PSR can cause numbness in all three trigeminal divisions if necessary, but once the ophthalmic division is to be included, balloon compression offers at least some protection of the corneal reflex. For some reason, corneal reflex nerve fibers seem to be less vulnerable to the pressure of the balloon than to the heat of the radiofrequency electrode.
Most patients are willing to exchange their TN pain for their mild new numbness. Over time, there is some diminishment of the numbness and some accommodation to it. Like putting on a new pair of shoes, the new sensation is stronger at first, but the brain starts to see it as the “new norm” over time. Recurrence of pain in spite of continued numbness is well known and one of the mysteries of the disease. It is presumed that this represents some intensification or progression of the disease, which must be within the nerve.
PSR can be repeated for recurrence, but each repeat procedure carries the need for more numbness and therefore the increased risk of troublesome numbness. PSR is one of the oldest and yet still one of the best procedures to relieve TN pain. It is an outpatient procedure with an acceptably low risk profile and can be an exceptionally good option for patients with medical reasons to avoid open surgery.
Glycerol injection is also an outpatient or overnight procedure. It is performed with intravenous sedation. A thin needle is introduced through a puncture in the cheek, next to the mouth and guided through a natural opening in the base of the skull. Just inside this opening is the trigeminal ganglion where all three nerves come together. A small amount of a substance called glycerol is injected into the nerve after your doctor identifies the fibers of the nerve using a special x-ray test. The glycerol bathes the ganglion. The glycerol inactivates the short-circuit of the pain fibers in the nerve.
Subscribe
Eye Movement Desensitization and Reprocessing (EMDR) is a psychotherapy treatment method proven to help people recover from trauma and other distressing life experiences, including PTSD, anxiety, depression, and panic disorders. This presentation will review the applications of EMDR for people with facial pain.
Neuromodulation can relieve various types of facial pain. Learn more about neuromodulation and whether it can help your face pain.
Dr. Steven Chang of Stanford University Medical Center and FPA Medical Advisory Board member reviews radiation treatment options for neuropathic facial pain.
Dr. Ramesh Babu answers some common questions about botox for facial pain.
Michele Cohen, LCSW and FPA Support Group Leader discusses the benefits of psychotherapy and support programs, including her own experience as someone with facial pain.
Microvascular decompression is a surgical treatment for neuropathic facial pain. Learn whether MVD is an option for you.
Dr. Jeffrey Cohen discusses non-surgical treatments.
Mindfulness has increasingly gained attention over the past few decades, as it is gradually implemented in medical care, hospitals, schools, and businesses.
Two people affected by neuropathic facial pain discuss their experience using medical marijuana.
What are trigeminal neuropathies? Learn about causes of facial pain and what you can do.
In this webinar, Dr. Jeffrey Brown, Chairman of the FPA Medical Advisory Board, talks about the top questions patients and their loved ones have regarding trigeminal neuralgia.
Medical cannabis has become a useful tool in the toolbox for people with facial pain. Learn more about cannabis for face pain.
Jennifer M. Wagner, Executive Director of the Western Pain Society, explains the brain-body connection with an emphasis on pain response and provides a list of strategies for those affected by chronic pain.
If you suffer from true migraine headaches, there are surgical treatments that may be appropriate for you.
Dr. Raymond Sekula, Professor of Neurosurgery at the University of Pittsburgh School of Medicine and Director of the Cranial Nerve Disorders Program at UPMC, and FPA Medical Advisory Board member reviews the challenges that can complicate the care of people with neuropathic facial pain.
Complementary health approaches offer natural, effective, and less-invasive methods for improving your pain and wellbeing.
Complementary health approaches, also referred to as complementary and alternative medicine (CAM), integrative health therapies, and other terms, refers to a group of diverse medical and health care systems, practices, […]
Medical disorders that affect the facial nerve may be the cause of your pain. Learn more about underlying conditions that cause face pain.
Dr. Jeffrey Brown, Chairman of the Facial Pain Association’s Medical Advisory Board, interviews Dr. Hossein Ansari on medical causes of neuropathic facial pain.
Facial pain can create fears and doubts. Learn about taking control of your life with facial pain.
When severe facial pain is an emergency, this guidance will inform the doctors how to treat you.
Worry about being able to afford your prescription medication while you are in pain adds to the frustration and fear for people with facial pain.
Neuropathic facial pain is diagnosed almost exclusively by the individual’s description of the symptoms. Dr. Kim Burchiel developed a list of questions to help doctors determine exactly which classification may describe a […]
Jonathan Greenberg, Research Staff Psychologist, Harvard Brain Integrative Health Clinic and Research Program will explain what mindfulness is and how it is used in therapeutic and other settings.
Maintaining dental health is important for people with face pain. These steps will help you stop avoiding the dentist.
Dr. Julie Pilitsis, Chair of the Department of Neuroscience & Experimental Therapeutics Professor of Neurosurgery Neuroscience and Experimental Therapeutics, Albany Medical Center and FPA Medical Advisory Board member presents an overview of trigeminal neuralgia and other neuropathic facial pains.
Jeffrey A. Brown, MD, FACS, FAANS First, some basic requirements: there are a lot, but that is the point, too. Doctors educated in the United States are granted their MD […]
Dr. Deborah Barrett offers a framework and tools to help people improve their quality of life, just as they are, while also reducing pain and suffering. Her work draws from empirically based cognitive and behavioral interventions, and she practices what she preaches every day.
Learn about getting a comprehensive orofacial pain evaluation and become an educated patient.
Dr. Derek Steinbacher, Director of Craniofacial Surgery, Yale Medicine, Chief of Oral Maxillofacial Surgery and Dentistry, FPA Medical Advisory Board member, reviews migraines, TMJ disorders, and dental pain.
By filling out the form below, you will receive a free FPA Patient Guide and periodic updates on the management and treatment of facial pain conditions. We do not share this information with any outside sources.
Sign up for our main newsletter
Connect on social
© 2002-2022 The Facial Pain Association, All rights reserved.
